Showing results (111-120 of 122) with videos related to
Sort By:
Pageof 13
Nature Communications|August 21, 2023
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection historyHailey Hornsby, Alexander R Nicols, Stephanie Longet, et al.The Journal of Experimental Medicine|April 20, 2022
Life-threatening viral disease in a novel form of autosomal recessive IFNAR2 deficiency in the ArcticChristopher J A Duncan, Morten K Skouboe, Sophie Howarth, et al.Scientific Reports|November 27, 2025
Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal antibody and T cell immunityBarbara Kronsteiner, Melissa Govender, Chang Liu, et al.The Journal of Infection|April 7, 2023
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccinesRobert H Shaw, Melanie Greenland, Arabella S V Stuart, et al.Lancet (London, England)|December 9, 2021
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trialArabella S V Stuart, Robert H Shaw, Xinxue Liu, et al.The Lancet. Microbe|November 15, 2021
T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort studyAdrienn Angyal, Stephanie Longet, Shona C Moore, et al.Cell|November 4, 2021
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccineRebecca P Payne, Stephanie Longet, James A Austin, et al.Lancet (London, England)|April 2, 2021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trialKatherine R W Emary, Tanya Golubchik, Parvinder K Aley, et al.Med (New York, N.Y.)|March 2, 2023
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimensShona C Moore, Barbara Kronsteiner, Stephanie Longet, et al.Nature Medicine|April 21, 2021
Single-cell multi-omics analysis of the immune response in COVID-19Emily Stephenson, Gary Reynolds, Rachel A Botting, et al.Pageof 13